PAR paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-19

  1. 18,369 Posts.
    lightbulb Created with Sketch. 5231
    Agreed, free options plus the likelihood of plenty of near term catalysts to keep the momentum running high. Ethics approval within the next few weeks, recruitment shortly after, then first dosing shortly after that. There’s of course the big one - the partnership - which could come at any moment. We know there’s a US trip planned for early Feb, perhaps they’ll also be signing a deal within the next few weeks?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
29.0¢
Change
-0.005(1.69%)
Mkt cap ! $112.9M
Open High Low Value Volume
29.5¢ 31.0¢ 28.5¢ $431.5K 1.469M

Buyers (Bids)

No. Vol. Price($)
3 21578 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 9000 1
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.